Enzychem Lifesciences Corp.
South Korean biopharma innovating oral small‑molecule therapeutics targeting unmet oncology, inflammatory, and respiratory conditions, with EC‑18 addressing fibrotic diseases like NASH and potential COVID‑19 treatment.
Headquarters: South Korea (KOR)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- HQ: Seoul
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.